Moderna COVID-19 vaccine authorised in Switzerland for children aged 6 to 11 years
Bern, 13.5.2022 - Swissmedic has authorised an extension of the indication of the Spikevax® COVID-19 vaccine from Moderna to children aged 6 to 11 years. Children aged 6 years and over, as opposed to adults and adolescents aged 12 years and above, will receive two half doses (50 micrograms), administered at an interval of four weeks.